Perfused hearts from Type 2 diabetic (db/db) mice show metabolic responsiveness to insulin

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 290, Issue 5, 2006, Pages

  Hafstad, Anne Dragøy ^a   Solevåg, Geir Helge ^a   Severson, David L ^b   Larsen, Terje S ^a   Aasum, Ellen ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Glucose and fatty acid metabolism; Insulin action; Myocardial metabolism

Indexed keywords

DEOXYGLUCOSE; FATTY ACID; GLUCOSE; INSULIN; PALMITIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FATTY ACID OXIDATION; GLUCOSE OXIDATION; GLUCOSE TRANSPORT; HEART FUNCTION; HEART MUSCLE METABOLISM; HEART PERFUSION; INSULIN RESISTANCE; INSULIN RESPONSE; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOSE; HEART; INSULIN; MALE; MICE; MICE, INBRED C57BL; MYOCARDIUM; PALMITIC ACID; PERFUSION;

EID: 33646396190     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.01063.2005     Document Type: Article

References (50)

1. Aasum E, Belke DD, Severson DL, Riemersma R, Cooper M, Andreassen M, and Larsen TS. Cardiac function and metabolism in Type 2 diabetic mice after treatment with BM 17.0744, a novel PPAR-α activator. Am J Physiol Heart Circ Physiol 283: H949-H957, 2002.
2. Aasum E, Hafstad AD, Severson DL, and Larsen TS. Age-dependent changes in metabolism, contractile function, and ischemic sensitivity in hearts from db/db mice. Diabetes 52: 434-441, 2003.
3. Belke DD, Betuing S, Tuttle MJ, Graveleau C, Young ME, Pham M, Zhang D, Cooksey RC, McClain DA, Litwin SE, Taegtmeyer H, Severson D, Kahn CR, and Abel ED. Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression. J Clin Invest 109: 629-639, 2002.
4. Belke DD, Larsen TS, Gibbs EM, and Severson DL. Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice. Am J Physiol Endocrinol Metab 279: E1104-E1113, 2000.
5. Belke DD, Larsen TS, Lopaschuk GD, and Severson DL. Glucose and fatty acid metabolism in the isolated working mouse heart. Am J Physiol Regul Integr Comp Physiol 277: R1210-R1217, 1999.
6. Bjorkegren J, Veniant M, Kim SK, Withycombe SK, Wood PA, Hellerstein MK, Neese RA, and Young SG. Lipoprotein secretion and triglyceride stores in the heart. J Biol Chem 276: 38511-38517, 2001.
7. Brazil DP, Yang ZZ, and Hemmings BA. Advances in protein kinase B signalling: AKTion on multiple fronts. Trends Biochem Sci 29: 233-242, 2004.
8. Brozinick JT, McCoid SC, Reynolds TH, Nardone NA, Hargrove DM, Stevenson RW, Cushman SW, and Gibbs EM. GLUT4 overexpression in db/db mice dose-dependently ameliorates diabetes but is not a lifelong cure. Diabetes 50: 593-600, 2001.
9. Carley AN, Semeniuk LM, Shimoni Y, Aasum E, Larsen TS, Berger JP, and Severson DL. Treatment of Type 2 diabetic db/db mice with a novel PPARγ agonist improves cardiac metabolism but not contractile function. Am J Physiol Endocrinol Metab 286: E449-E455, 2004.
10. Carley AN and Severson DL. Fatty acid metabolism is enhanced in type 2 diabetic hearts. Biochem Biophys Acta 1734: 112-126, 2005.
11. Carroll R, Carley AN, Dyck JR, and Severson DL. Metabolic effects of insulin on cardiomyocytes from control and diabetic db/db mouse hearts. Am J Physiol Endocrinol Metab 288: E900-E906, 2005.
12. Coleman DL. Diabetes-obesity syndromes in mice. Diabetes 31: 1-6, 1982.
13. Coort SL, Luiken JJ, van der Vusse GJ, Bonen A, and Glatz JF. Increased FAT (fatty acid translocase)/CD36-mediated long-chain fatty acid uptake in cardiac myocytes from obese Zucker rats. Biochem Soc Trans 32: 83-85, 2004.
14. Depre C, Shipley GL, Chen W, Han Q, Doenst T, Moore ML, Stepkowski S, Davies PJ, and Taegtmeyer H. Unloaded heart in vivo replicates fetal gene expression of cardiac hypertrophy. Nat Med 4: 1269-1275, 1998.
15. Desrois M, Sidell RJ, Gauguier D, King LM, Radda GK, and Clarke K. Initial steps of insulin signaling and glucose transport are defective in the type 2 diabetic rat heart. Cardiovasc Res 61: 288-296, 2004.
16. Doenst T, Richwine RT, Bray MS, Goodwin GW, Frazier OH, and Taegtmeyer H. Insulin improves functional and metabolic recovery of reperfused working rat heart. Ann Thorac Surg 67: 1682-1688, 1999.
17. Finck BN and Kelly DP. Peroxisome proliferator-activated receptor α (PPARα) signaling in the gene regulatory control of energy metabolism in the normal and diseased heart. J Mol Cell Cardiol 34: 1249-1257, 2002.
18. Gibbs EM, Stock JL, McCoid SC, Stukenbrok HA, Pessin JE, Stevenson RW, Milici AJ, and McNeish JD. Glycemic improvement in diabetic db/db mice by overexpression of the human insulin-regulatable glucose transporter (GLUT4). J Clin Invest 95: 1512-1518, 1995.
19. Hori H, Sasaoka T, Ishihara H, Wada T, Murakami S, Ishiki M, and Kobayashi M. Association of SH2-containing inositol phosphatase 2 with the insulin resistance of diabetic db/db mice. Diabetes 51: 2387-2394, 2002.
20. How OJ, Aasum E, Kunnathu S, Severson DL, Myhre ES, and Larsen TS. Influence of substrate supply on cardiac efficiency, as measured by pressure-volume analysis in ex vivo mouse hearts. Am J Physiol Heart Circ Physiol 288: H2979-H2985, 2005.
21. Huisamen B. Protein kinase B in the diabetic heart. Mol Cell Biochem 249: 31-38, 2003.
22. Jagasia D, Whiting JM, Concato J, Pfau S, and McNulty PH. Effect of non-insulin-dependent diabetes mellitus on myocardial insulin responsiveness in patients with ischemic heart disease. Circulation 103: 1734-1739, 2001.
23. Jeffrey FM, Diczku V, Sherry AD, and Malloy CR. Substrate selection in the isolated working rat heart: effects of reperfusion, afterload, and concentration. Basic Res Cardiol 90: 388-396, 1995.
24. Kodama H, Fujita M, and Yamaguchi I. Development of hyperglycaemia and insulin resistance in conscious genetically diabetic (C57BL/KsJ-db/db) mice. Diabetologia 37: 739-744, 1994.
25. Kolter T, Uphues I, and Eckel J. Molecular analysis of insulin resistance in isolated ventricular cardiomyocytes of obese Zucker rats. Am J Physiol Endocrinol Metab 273: E59-E67, 1997.
26. Kovacic S, Soltys CL, Barr AJ, Shiojima I, Walsh K, and Dyck JR. Akt activity negatively regulates phosphorylation of AMP-activated protein kinase in the heart. J Biol Chem 278: 39422-39427, 2003.
27. Kuang M, Febbraio M, Wagg C, Lopaschuk GD, and Dyck JR. Fatty acid translocase/CD36 deficiency does not energetically or functionally compromise hearts before or after ischemia. Circulation 109: 1550-1557, 2004.
28. Larsen TS, Dani R, Giles RW, Severson DL, Lopaschuk GD, Belke DD, and Tyberg JV. The isolated working mouse heart: methodological considerations. Pflügers Arch 437: 979-985, 1999.
29. Lazar HL, Chipkin S, Philippides G, Bao Y, and Apstein C. Glucose-insulin-potassium solutions improve outcomes in diabetics who have coronary artery operations. Ann Thorac Surg 70: 145-150, 2000.
30. Lloyd S, Brocks C, and Chatham JC. Differential modulation of glucose, lactate, and pyruvate oxidation by insulin and dichloroacetate in the rat heart. Am J Physiol Heart Circ Physiol 285: H163-H172, 2003.
31. Lopaschuk GD. Treating ischemic heart disease by pharmacologically improving cardiac energy metabolism. Am J Cardiol 82: 14K-17K, 1998.
32. Malmberg K, Ryden L, Efendic S, Herlitz J, Nicol P, Waldenstrom A, Wedel H, and Welin L. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol 26: 57-65, 1995.
33. Mazumder PK, O'Neill BT, Roberts MW, Buchanan J, Yun UJ, Cooksey RC, Boudina S, and Abel ED. Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts. Diabetes 53: 2366-2374, 2004.
34. McNulty PH, Liu WX, Luba MC, Valenti JA, Letsou GV, and Baldwin JC. Effect of nonworking heterotopic transplantation on rat heart glycogen metabolism. Am J Physiol Endocrinol Metab 268: E48-E54, 1995.
35. Murat I, Veksler VI, and Ventura Clapier R. Effects of halothane on contractile properties of skinned fibers from cardiomyopathic animals. J Mol Cell Cardiol 21: 1293-1304, 1989.
36. Oakes ND, Kjellstedt A, Forsberg GB, Clementz T, Camejo G, Furler SM, Kraegen EW, Olwegard-Halvarsson M, Jenkins AB, and Ljung B. Development and initial evaluation of a novel method for assessing tissue-specific plasma free fatty acid utilization in vivo using (R)-2-bromopalmitate tracer. J Lipid Res 40: 1155-1169, 1999.
37. Passonneau JV and Lauderdale VR. A comparison of three methods of glycogen measurement in tissue. Anal Biochem 60: 405-412, 1974.
38. Randle PJ. Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years. Diabetes Metab Rev 14: 263-283, 1998.
39. Sakamoto J, Barr RL, Kavanagh KM, and Lopaschuk GD. Contribution of malonyl-CoA decarboxylase to the high fatty acid oxidation rates seen in the diabetic heart. Am J Physiol Heart Circ Physiol 278: H1196-H1204, 2000.
40. Saltiel AR and Kahn CR. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414: 799-806, 2001.
41. Schaap FG, Binas B, Danneberg H, van der Vusse GJ, and Glatz JF. Impaired long-chain fatty acid utilization by cardiac myocytes isolated from mice lacking the heart-type fatty acid binding protein gene. Circ Res 85: 329-337, 1999.
42. Shao J, Yamashita H, Qiao L, and Friedman JE. Decreased Akt kinase activity and insulin resistance in C57BL/KsJ-Lepr db/db mice. J Endocrinol 167: 107-115, 2000.
43. Shen Q, Cline GW, Shulman GI, Leibowitz MD, and Davies PJ. Effects of rexinoids on glucose transport and insulin-mediated signaling in skeletal muscles of diabetic (db/db) mice. J Biol Chem 279: 19721-19731, 2004.
44. Soltys CL, Buchholz L, Gandhi M, Clanachan AS, Walsh K, and Dyck JR. Phosphorylation of cardiac protein kinase B is regulated by palmitate. Am J Physiol Heart Circ Physiol 283: H1056-H1064, 2002.
45. Stanley WC, Lopaschuk GD, and McCormack JG. Regulation of energy substrate metabolism in the diabetic heart. Cardiovasc Res 34: 25-33, 1997.
46. Taegtmeyer H, Goodwin GW, Doenst T, and Frazier OH. Substrate metabolism as a determinant for postischemic functional recovery of the heart. Am J Cardiol 80: 3A-10A, 1997.
47. Taegtmeyer H, McNulty P, and Young ME. Adaptation and maladaptation of the heart in diabetes. I. General concepts. Circulation 105: 1727-1733, 2002.
48. Utriainen T, Takala T, Luotolahti M, Ronnemaa T, Laine H, Ruotsalainen U, Haaparanta M, Nuutila P, and Yki-Jarvinen H. Insulin resistance characterizes glucose uptake in skeletal muscle but not in the heart in NIDDM. Diabetologia 41: 555-559, 1998.
49. Young ME, McNulty P, and Taegtmeyer H. Adaptation and maladaptation of the heart in diabetes. II. Potential mechanisms. Circulation 105: 1861-1870, 2002.
50. Zaninetti D, Greco-Perotto R, Assimacopoulos-Jeannet F, and Jeanrenaud B. Dysregulation of glucose transport and transporters in perfused hearts of genetically obese (fa/fa) rats. Diabetologia 32: 56-60, 1989.